Phase 2 study of the antitumour activity and safety of simlukafusp alfa (FAP-IL2v) combined with atezolizumab in patients with recurrent and/or metastatic cervical squamous cell carcinoma
Phase 2 study of the antitumour activity and safety of simlukafusp alfa (FAP-IL2v) combined with atezolizumab in patients with recurrent and/or metastatic cervical squamous cell carcinoma
Álvaro Taus, Muriel Richard, Mahmut Gümüş, Susana Roselló‐Keränen et al.
Citations
8 citations
Journal
EBioMedicine
Topics
Cancer Immunotherapy and Biomarkers
Field-Weighted Citation Impact (FWCI)
2.26
article
Phase 2 study of the antitumour activity and safety of simlukafusp alfa (FAP-IL2v) combined with atezolizumab in patients with recurrent and/or metastatic cervical squamous cell carcinoma
Álvaro Taus, Muriel Richard, Mahmut Gümüş, Susana Roselló‐Keränen, Çağatay Arslan, Nassim Sleiman, Colin R. Lindsay, Eva María Guerra Alia, A. Yu. Smolin, Daniel Marbach, Ruth Perets, Vladimir Moiseyenko, Diégo Tosi, Nino Keshelava, Iwona Ługowska, Sylvie Rottey, Stefan Evers, Sema Sezgin Göksu, David Dejardin, Rafał Dziadziuszko, İrfan Çiçin, Hans Prenen, Antoîne Italiano, Christophe Boetsch, Ana Oaknin, Sanjeev Deva, Anton Kraxner, Loïc Verlingue, Jehad Charo, Volker Teichgräber, Caroline Ardeshir, Christin Habigt
article en
8 citations
Abstract
No abstract available for this paper.
Publication Tag
EBioMedicineVol. 109
Institutions
Roche (Switzerland) (CH), Trakya University (TR), Izmir University (TR), Akdeniz University (TR), Instituto Cajal (ES), Ghent University Hospital (BE), Rambam Health Care Campus (IL), Auckland City Hospital (NZ), Institut Gustave Roussy (FR), Antwerp University Hospital (BE), Roche (United Kingdom) (GB), Burdenko Neurosurgery Institute (RU), Vall d'Hebron Hospital Universitari (ES), Hospital Del Mar (ES), The Christie NHS Foundation Trust (GB), Institut Bergonié (FR), Institut de Recherche en Cancérologie de Montpellier (FR), The Maria Sklodowska-Curie National Research Institute of Oncology (PL), INCLIVA Health Research Institute (ES), Republican Scientific and Practical Center of Neurology and Neurosurgery (BY), Vall d'Hebron Institute of Oncology (ES), Istanbul Medeniyet University (TR), Gdańsk Medical University (PL)